Skip to main content
. 2006 Apr;55(4):505–509. doi: 10.1136/gut.2005.074815

graphic file with name gt74815.f4.jpg

Figure 4 Dermatology life quality index (DLQI) scores for the placebo and infliximab therapy groups. Using the DLQI, lower scores indicate health, and this shows a reduction in the scores after infusion of infliximab at week 2 in the infliximab group and at week 4 in the placebo group.